Articles published by GENENTA SCIENCE SPA
Genenta to Present at Upcoming Scientific and Investor Conferences
September 06, 2023
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers
GNTA
Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments
July 28, 2023
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers
GNTA
The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma
June 29, 2023
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers
GNTA
Genenta to Provide Update on Lead Product Temferon™
May 16, 2023
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers
GNTA
Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing
April 26, 2023
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers
GNTA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free